Persistent Asset Partners LTD Tg Therapeutics, Inc. Transaction History
Persistent Asset Partners LTD
- $135 Billion
- Q2 2025
A detailed history of Persistent Asset Partners LTD transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Persistent Asset Partners LTD holds 85,580 shares of TGTX stock, worth $2.88 Million. This represents 2.28% of its overall portfolio holdings.
Number of Shares
85,580
Previous 36,072
137.25%
Holding current value
$2.88 Million
Previous $1.42 Billion
116.55%
% of portfolio
2.28%
Previous 1.19%
Shares
3 transactions
Others Institutions Holding TGTX
# of Institutions
407Shares Held
91.5MCall Options Held
2.28MPut Options Held
1.68M-
Vanguard Group Inc Valley Forge, PA15.8MShares$533 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$384 Million0.0% of portfolio
-
State Street Corp Boston, MA7.62MShares$257 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA3.49MShares$118 Million0.01% of portfolio
-
Clearbridge Investments, LLC New York, NY3.05MShares$103 Million0.09% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $4.89B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...